New
Service for TodaysSeniorsNetwork.com
readers...roll mouse over, click on
highlighted links in stories to review items
from Amazon
Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
New Consumer
and Clinician guides on benefits, risks of
Rheumatoid Arthritis medicines
Newswise — A new pair of plain language
guides from the federal government draws on
unbiased scientific evidence to compare
rheumatoid arthritis drugs, including their
clinical benefits, risks and cost estimates.
The clinician and consumer guides include
basic facts about rheumatoid arthritis and
three classes of available medicines:
synthetic disease-modifying antirheumatic
drugs (DMARDs), biologic DMARDs, and
corticosteroids. The consumers guide
compares the benefits and risks of several
rheumatoid arthritis drugs that are
currently used alone and in combination.
The clinician guide contains more detailed
information, including ratings that measure
the strength of evidence on numerous
findings. Both guides include estimated
monthly costs for the medications.
The guides are the latest in a series of
AHRQ publications that help clinicians and
patients make the best possible treatment
choices.
Other guides produced by AHRQ compare
treatments for diabetes, depression,
gastroesophageal reflux disease (GERD), high
blood pressure, narrowed kidney arteries and
osteoarthritis.
...
...
...